C20H18FNO4 CAS 189028 93 1 Ezetimibe Intermediates ZT-4 GMP standard

CAS : 189028-93-1 Ezetimibe Intermediates C20H18FNO4 GMP standard

Chemical Name : ( 4S ) - 3 - [ 5 - ( 4 - Fluorophenyl ) - 1 , 5 - dioxopenyl ] - 4 - phenyl - 2 - oxazolidinone

CAS No . : 189028-93-1

Synonyms : 3 - [ 5 - ( 4 - fluorophenyl ) - 1 , 5 - dioxopentyl ] - 4 - phenyl - ( 4S ) - 2 - oxazolidinone ; 1 - ( 4 - fluorophenyl ) - 5 - [ ( 4S ) - 2 - oxo - 4 - phenyl - 1 , 3 - oxazolidin - 3 - yl ] pentane - 1 , 5 - dione

Short Code : ZT-4

Molecular Formula : C20H18FNO4

Molecular Weight : 355.365

Usuage: Ezetimibe Intermediates

Description: Ezetimibe is the active pharmaceutical ingredient (API) of branded drug Zetia, or one of the active pharmaceutical ingredients (API) of branded drug Liptruzet (the other API is atorvastatin) or Vytorin (the other API is simivastatin). It was innovated by Schering-Plough Pharmaceuticals and co-marketed with Merck/MSD. Ezetimibe is used to reduce the amount of cholesterol and other fatty substances in the blood. It may be used alone or with other statins such as atorvastatin and simivastatin.

( 4S ) - 3 - [ 5 - ( 4 - Fluorophenyl ) - 1 , 5 - dioxopenyl ] - 4 - phenyl - 2 - oxazolidinone CAS No . : 189028-93-1 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries. We strictly obey the laws and our commercial products are manufactured without infringing such patents. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.